Posts tagged “Biotech & Life Science”
There were jokes. There were fond reminiscences. There were stories about hard times endured and challenges overcome. But most of all, there were testaments of great pride and appreciation from the leaders who shaped, nurtured and built Biogen's giant Research Triangle Park biomanufacturing campus into one of the world's leading biotechnology manufacturing sites.
vTv Therapeutics, which is focused on development of a treatment for Alzheimer's, went public on the Nasdaq on Thursday. The company raised more than $117 million, selling nearly 8 million shares. However, share value collapsed during the day, plummeting 28 percent.
In a conference call, GlaxoSmithKline's top executive is asked if he would consider "pairing up" with another drug company. Back in May, an analyst started talk of a "PfizerKline" merger. GSK's CEO Andrew Witty notes a merger would be a "big issue to cross."
As many as 200 former GlaxoSmithKline employees who were transferred to life science services firm Parexel earlier this year are reportedly being laid off today. However, the Boston-based company which has a large presence in the Triangle, isn't talking.
Durham-based Baebies, a health-screening startup, has raised $13 million in equity financing, the company said Monday. Backers include Rex Health Ventures, Duke Angel Network, Duke University's DUMAC, and the NC Biotechnology Center.
Atmospheric Plasma Solutions, a Cary-based company with strategic ties to North Carolina State University is seeking $1.5 million in equity, according to a regulatory filing. It uses plasma technology to enable a wide range of materials processing options that may otherwise be out of reach, such as a process that previously required costly and dangerous chemicals or high temperatures.
Jody Kearns doesn't like to spend time obsessing about her Parkinson's disease. The 56-year-old dietitian from Syracuse, New York, had to give up bicycling because the disorder affected her balance. But she still works, drives and tries to live a normal life.
Cambridge, MA-based Biogen Inc., saw its stock price fall after slashing its guidance outlook for the rest of the year in its second quarter earnings report. The company also said it received FDA approval to make its multiple schlerosis drug at its Durham plant.
As the CEO of Vascular Biosciences (VBS), I was very excited to be notified by the Biotechnology Innovation Organization (BIO) that our company was the 2015 "Buzz of BIO" award winner in the "Pipelines of Promise" category.
North Carolina's Raleigh-Durham region, a.k.a. the Research Triangle, has the nation's second leading life science base among major metro areas, up from No. 4 since last year, according to a new report.
The numbers are in for the most recent quarter and the end of fiscal 2015: The N.C. Biotechnology Center reports awarding $1.8 million in grants and loans for the most recent quarter, adding up to nearly $6.8 million for the year.
Dr. Mary-Dell Chilton hasn't yet won a Nobel Prize. Yet. But her trophy case is already full of bioscience biggies. This year, for example, she was finally inducted into the National Inventors Hall of Fame. And she was made a World Food Prize laureate in 2013. In 2002 she received the Benjamin Franklin Medal from the Franklin Institute in Philadelphia, joining a roster of winners including Alexander Graham Bell, Thomas Edison, Pierre and Marie Curie, Albert Einstein and Stephen Hawking. In a talk at the NC Biotechnology Center, she recounts her career and the opportunities she sees in the future for plant science - "the best of times and the worst of times."
In today's Bulldog wrapup of technology and life science news: Stephen Hawking goes looking for ET; cheating website Ashley Madison is hacked; SpaceX says a strut failure doomed a rocket; and a strong dollar hurts Novartis.
The countdown is nearing zero for the fourth annual Innovate Raleigh Summit. Plus, High-tech accelerator Techstars is bringing its program to help veterans who want to become entrepreneurs - called Patriot Boot Camp - to Chapel Hill. Plus, other tech events.